Latest Ratings for MIRM Date Firm Action From To Mar 2022 Raymond James Maintains Strong Buy Jan 2022 SVB Leerink Maintains Outperform Jan 2022 Raymond James Maintains Strong Buy View More Analyst Ratings for MIRM View the Latest Analyst Ratings Importance Rank: 1 read more